WEDNESDAY, Nov. 23, 2022 (HealthDay News) — People with one form of the genetic blood disorder hemophilia now have a one-time treatment with a $3.5 million price tag. The U.S. Food and Drug Administration approved the new gene therapy Hemgenix on Nov. 22. Soon after, drugmaker CSL Behring revealed itsContinue Reading

WEDNESDAY, Sept. 21, 2022 (HealthDay News) — Too few children with sickle cell anemia are getting the recommended screening tests for stroke, a common complication of this disease, a new government report finds. What’s more, many aren’t receiving hydroxyurea, a medication that can reduce the complications associated with the bloodContinue Reading

TUESDAY, Sept. 6, 2022 (HealthDay News) — A network that receives and supplies blood for transfusions nationwide is calling for more diverse blood donors. Less than 20% of blood donations are from people of color, but those donations are essential. Frequently transfused patients often require blood from donors with similarContinue Reading

WEDNESDAY, Aug. 31, 2022 (HealthDay News) — When teenagers with type 1 diabetes get better control of their blood sugar, their brains may benefit, a new clinical trial shows. Researchers found that when teenagers started treatment with a newer technology — often dubbed “artificial pancreas” systems — they were betterContinue Reading

TUESDAY, Aug. 2, 2022 (HealthDay News) — A daily hamburger might raise the risk of developing heart disease, but not necessarily for the reasons people often think, new research suggests. The study of nearly 4,000 older Americans found what many have before: People who ate a lot of red meatContinue Reading